CHARACTERIZATION OF DYSKINESIAS INDUCED BY L-DOPA IN MPTP-TREATED SQUIRREL-MONKEYS

被引:51
|
作者
BOYCE, S
RUPNIAK, NMJ
STEVENTON, MJ
IVERSEN, SD
机构
[1] Merck Sharp and Dohme Research Laboratories, Neuroscience Research Centre, Harlow, CM20 2QR, Essex, Terlings Park
关键词
Chorea; Dystonia; l-dopa; Parkinson's disease; Squirrel monkey;
D O I
10.1007/BF02245739
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Intermittent treatment with l-dopa over a 2-year period induced abnormal involuntary movements in MPTP-treated squirrel monkeys. Dyskinesias included a choreic and dystonic component. Dose-response curves for chorea and dystonia revealed that the same dose of l-dopa (30 mg/kg) induced the highest score for both dyskinesias; however, the severity was much greater for chorea. Choreic movements were always most prevalent at the time of peak effect, whereas dystonia was apparent at the time of peak effect and at "end-of-dose", and was occasionally observed spontaneously. Our findings indicate that squirrel monkeys treated with MPTP develop l-dopa-induced dyskinesias which closely resemble those observed in Parkinson's disease. This species provides a valuable animal model to develop improved therapeutic agents. © 1990 Springer-Verlag.
引用
收藏
页码:21 / 27
页数:7
相关论文
共 50 条
  • [31] Memantine improves L-dopa induced dyskinesias
    Varanese, S.
    Howard, J.
    Di Rocco, A.
    MOVEMENT DISORDERS, 2009, 24 : S360 - S360
  • [32] Effects of monoamine oxidase inhibitors and/or L-DOPA on neurons in substantia nigra of MPTP-treated mice
    Fukuda, T
    Tanaka, J
    BRAIN PATHOLOGY, 1997, 7 (04) : 1389 - 1389
  • [33] EFFECTS OF L-DOPA ON PREPROENKEPHALIN AND PREPROTACHYKININ GENE-EXPRESSION IN THE MPTP-TREATED MONKEY STRIATUM
    HERRERO, MT
    AUGOOD, SJ
    HIRSCH, EC
    JAVOYAGID, F
    LUQUIN, MR
    AGID, Y
    OBESO, JA
    EMSON, PC
    NEUROSCIENCE, 1995, 68 (04) : 1189 - 1198
  • [34] Nur77 mRNA levels and L-Dopa-induced dyskinesias in MPTP monkeys treated with docosahexaenoic acid
    Mahmoudi, Souha
    Samadi, Pershia
    Gilbert, Francois
    Ouattara, Bazoumana
    Morissette, Marc
    Gregoire, Laurent
    Rouillard, Claude
    Di Paolo, Therese
    Levesque, Daniel
    NEUROBIOLOGY OF DISEASE, 2009, 36 (01) : 213 - 222
  • [35] SYNERGISTIC INTERACTIONS BETWEEN NMDA-ANTAGONISTS AND L-DOPA ON ACTIVITY IN MPTP-TREATED MICE
    FREDRIKSSON, A
    GENTSCH, C
    ARCHER, T
    JOURNAL OF NEURAL TRANSMISSION-GENERAL SECTION, 1994, 97 (03) : 197 - 209
  • [36] A comparison of ropinirole, L-dopa, and bromocriptine treatment on the development of dyskinesia in MPTP-treated common marmosets
    Jenner, P
    Pearce, RKB
    Banerji, T
    Desai, NB
    Jackson, MJ
    Marsden, CD
    NEUROLOGY, 1997, 48 (03) : 2085 - 2085
  • [37] The fictions of L-DOPA and dopamine agonists following dopamine depletion in MPTP-treated common marmosets
    Treseder, SA
    Smith, L
    Jackson, M
    Jenner, P
    Marsden, CD
    BRITISH JOURNAL OF PHARMACOLOGY, 1998, 123 : U145 - U145
  • [38] DIFFERENTIAL-EFFECTS OF D-1 AND D-2 DOPAMINE AGONISTS IN MPTP-TREATED SQUIRREL-MONKEYS
    BOYCE, S
    RUPNIAK, NMJ
    STEVENTON, MJ
    IVERSEN, SD
    PSYCHOPHARMACOLOGY, 1990, 101 : S7 - S7
  • [39] L-Dopa induced dyskinesias in Parkinsonian mice: Disease severity or L-Dopa history
    Shan, Lufei
    Diaz, Oscar
    Zhang, Yajun
    Ladenheim, Bruce
    Cadet, Jean-Lud
    Chiang, Yung-Hsiao
    Olson, Lars
    Hoffer, Barry J.
    Baeckman, Cristina M.
    BRAIN RESEARCH, 2015, 1618 : 261 - 269
  • [40] Effects of perampanel, a selective amPA receptor antagonist, on L-DOPA-induced dyskinesia in MPTP-treated cynomolgus monkeys
    Mizuta, Eiji
    Ueno, Masataka
    Hanada, Takahisa
    Kuno, Sadako
    NEUROLOGY, 2008, 70 (11) : A323 - A323